923 related articles for article (PubMed ID: 17719070)
1. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
Gromowski GD; Barrett AD
Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
[TBL] [Abstract][Full Text] [Related]
2. Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III.
Matsui K; Gromowski GD; Li L; Schuh AJ; Lee JC; Barrett AD
Virology; 2009 Feb; 384(1):16-20. PubMed ID: 19101005
[TBL] [Abstract][Full Text] [Related]
3. Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus.
Gromowski GD; Barrett ND; Barrett AD
J Virol; 2008 Sep; 82(17):8828-37. PubMed ID: 18562544
[TBL] [Abstract][Full Text] [Related]
4. Mutations of an antibody binding energy hot spot on domain III of the dengue 2 envelope glycoprotein exploited for neutralization escape.
Gromowski GD; Roehrig JT; Diamond MS; Lee JC; Pitcher TJ; Barrett AD
Virology; 2010 Nov; 407(2):237-46. PubMed ID: 20832836
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
Roehrig JT; Bolin RA; Kelly RG
Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence.
Hiramatsu K; Tadano M; Men R; Lai CJ
Virology; 1996 Oct; 224(2):437-45. PubMed ID: 8874504
[TBL] [Abstract][Full Text] [Related]
7. Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein.
Goncalvez AP; Purcell RH; Lai CJ
J Virol; 2004 Dec; 78(23):12919-28. PubMed ID: 15542644
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a dengue type-specific epitope on dengue 3 virus envelope protein domain III.
Matsui K; Gromowski GD; Li L; Barrett AD
J Gen Virol; 2010 Sep; 91(Pt 9):2249-53. PubMed ID: 20444995
[TBL] [Abstract][Full Text] [Related]
9. Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus.
Bonaldo MC; Garratt RC; Caufour PS; Freire MS; Rodrigues MM; Nussenzweig RS; Galler R
J Mol Biol; 2002 Jan; 315(4):873-85. PubMed ID: 11812154
[TBL] [Abstract][Full Text] [Related]
10. Neutralization determinants of laboratory strains and field isolates of equine arteritis virus: identification of four neutralization sites in the amino-terminal ectodomain of the G(L) envelope glycoprotein.
Balasuriya UB; Patton JF; Rossitto PV; Timoney PJ; McCollum WH; MacLachlan NJ
Virology; 1997 May; 232(1):114-28. PubMed ID: 9185595
[TBL] [Abstract][Full Text] [Related]
11. Antibodies specific for the antigenic domain 1 of glycoprotein B (gpUL55) of human cytomegalovirus bind to different substructures.
Schoppel K; Hassfurther E; Britt W; Ohlin M; Borrebaeck CA; Mach M
Virology; 1996 Feb; 216(1):133-45. PubMed ID: 8614980
[TBL] [Abstract][Full Text] [Related]
12. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes.
Sukupolvi-Petty S; Austin SK; Purtha WE; Oliphant T; Nybakken GE; Schlesinger JJ; Roehrig JT; Gromowski GD; Barrett AD; Fremont DH; Diamond MS
J Virol; 2007 Dec; 81(23):12816-26. PubMed ID: 17881453
[TBL] [Abstract][Full Text] [Related]
13. Fine mapping of neutralization epitopes on duck hepatitis B virus (DHBV) pre-S protein using monoclonal antibodies and overlapping peptides.
Chassot S; Lambert V; Kay A; Godinot C; Roux B; Trepo C; Cova L
Virology; 1993 Jan; 192(1):217-23. PubMed ID: 7685963
[TBL] [Abstract][Full Text] [Related]
14. Dengue virus type 2 envelope protein displayed as recombinant phage attachment protein reveals potential cell binding sites.
Abd-Jamil J; Cheah CY; AbuBakar S
Protein Eng Des Sel; 2008 Oct; 21(10):605-11. PubMed ID: 18669522
[TBL] [Abstract][Full Text] [Related]
15. Identification of a neutralization site in the major envelope glycoprotein (GL) of equine arteritis virus.
Balasuriya UB; Maclachlan NJ; De Vries AA; Rossitto PV; Rottier PJ
Virology; 1995 Mar; 207(2):518-27. PubMed ID: 7533965
[TBL] [Abstract][Full Text] [Related]
16. Genotype-specific neutralization and protection by antibodies against dengue virus type 3.
Brien JD; Austin SK; Sukupolvi-Petty S; O'Brien KM; Johnson S; Fremont DH; Diamond MS
J Virol; 2010 Oct; 84(20):10630-43. PubMed ID: 20702644
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive mapping of immunodominant and conserved serotype- and group-specific B-cell epitopes of nonstructural protein 1 from dengue virus type 1.
Chen Y; Pan Y; Guo Y; Qiu L; Ding X; Che X
Virology; 2010 Mar; 398(2):290-8. PubMed ID: 20079511
[TBL] [Abstract][Full Text] [Related]
18. A DENV-2-type-specific monoclonal antibody binds to the DENV-complex-reactive antigenic site on envelope protein domain 3.
Sarathy VV; Pitcher TJ; Gromowski GD; Roehrig JT; Barrett ADT
J Gen Virol; 2017 Jun; 98(6):1299-1304. PubMed ID: 28631593
[TBL] [Abstract][Full Text] [Related]
19. A single amino acid change within antigenic domain II of the spike protein of bovine coronavirus confers resistance to virus neutralization.
Yoo D; Deregt D
Clin Diagn Lab Immunol; 2001 Mar; 8(2):297-302. PubMed ID: 11238212
[TBL] [Abstract][Full Text] [Related]
20. Antigenic domains analysis of classical swine fever virus E2 glycoprotein by mutagenesis and conformation-dependent monoclonal antibodies.
Chang CY; Huang CC; Lin YJ; Deng MC; Chen HC; Tsai CH; Chang WM; Wang FI
Virus Res; 2010 May; 149(2):183-9. PubMed ID: 20132851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
